Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07760857
Investigation of an Intelligent Centre-adaptive Multi-modal Fusion Framework (Cad- MMFF) to Overcome Unnecessary Prostate Biopsies and Optimize MRI UtilizationChinese University of Hong KongNot Yet Recruiting
NCT07760857Not Yet Recruiting
—
Investigation of an Intelligent Centre-adaptive Multi-modal Fusion Framework (Ca...Chinese University of Hon...
NCT07761598
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs instituteNot Yet RecruitingNot Applicable
NCT07761598Not Yet Recruiting
Not Applicable
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs institute
NCT07760831
A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative ColitisJiangsu HengRui Medicine Co., Ltd.Not Yet RecruitingPhase 1
NCT07760831Not Yet Recruiting
Phase 1
A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerativ...Jiangsu HengRui Medicine...
NCT07760506
The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic HealthApplied Science & Performance InstituteNot Yet RecruitingNot Applicable
NCT07760506Not Yet Recruiting
Not Applicable
The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting...Applied Science & Perform...
NCT07761702
Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-Risk AMLShanghai Jiao Tong University School of MedicineNot Yet RecruitingPhase 3
NCT07761702Not Yet Recruiting
Phase 3
Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-...Shanghai Jiao Tong Univer...
NCT07760597
Effects of Exercise Frequency on Muscle Size and Strength in Healthy, Untrained Young AdultsCameron MitchellNot Yet RecruitingNot Applicable
NCT07760597Not Yet Recruiting
Not Applicable
Effects of Exercise Frequency on Muscle Size and Strength in Healthy, Untrained...Cameron Mitchell
NCT07760961
Effect of Mizagliflozin on Hypoglycemia in Patients With Post-Bariatric HypoglycemiaVogenx, Inc.Not Yet RecruitingPhase 2
NCT07760961Not Yet Recruiting
Phase 2
Effect of Mizagliflozin on Hypoglycemia in Patients With Post-Bariatric Hypoglyc...Vogenx, Inc.
NCT07760077
Phase I Study of QLS1510 Tablets in Healthy ParticipantsShanghai Qilu Pharmaceutical Research and Development Center LTDNot Yet RecruitingPhase 1
NCT07760077Not Yet Recruiting
Phase 1
Phase I Study of QLS1510 Tablets in Healthy ParticipantsShanghai Qilu Pharmaceuti...
NCT07760454
A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple MyelomaUCARsgen Biotech LimitedNot Yet RecruitingPhase 1
NCT07760454Not Yet Recruiting
Phase 1
A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple MyelomaUCARsgen Biotech Limited
NCT07761286
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular CarcinomaCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 1
NCT07761286Not Yet Recruiting
Phase 1
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection f...CSPC Megalith Biopharmace...
NCT07759778
Oliceridine-Propofol Dose for Gastroscope Insertion in Obese PatientsLu YiNot Yet RecruitingPhase 4
NCT07759778Not Yet Recruiting
Phase 4
Oliceridine-Propofol Dose for Gastroscope Insertion in Obese PatientsLu Yi
NCT07760675
Evaluating in Person Curriculum for Educating Obstetrical Residents on Better Caring for 2 Spirit Metis Patients Using and AI Assisted OSCE.Canadian Institutes of Health Research (CIHR)Not Yet RecruitingNot Applicable
NCT07760675Not Yet Recruiting
Not Applicable
Evaluating in Person Curriculum for Educating Obstetrical Residents on Better Ca...Canadian Institutes of He...
NCT07760818
A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)argenxNot Yet RecruitingPhase 2
NCT07760818Not Yet Recruiting
Phase 2
A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's D...argenx
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07759362
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)Endo USA Inc., a Keenova Therapeutics CompanyNot Yet RecruitingPhase 3
NCT07759362Not Yet Recruiting
Phase 3
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT...Endo USA Inc., a Keenova...
NCT07760350
Assessing the Feasibility of the "Heart Care Pairs" InterventionNational Institute on Minority Health and Health Disparities (NIMHD)Not Yet RecruitingNot Applicable
NCT07760350Not Yet Recruiting
Not Applicable
Assessing the Feasibility of the "Heart Care Pairs" InterventionNational Institute on Min...
NCT07759180
Sterile Plant-Based Gauze for Eyelid Hygiene in Anterior BlepharitisAzienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'AragonaCompletedNot Applicable
NCT07759180Completed
Not Applicable
Sterile Plant-Based Gauze for Eyelid Hygiene in Anterior BlepharitisAzienda Ospedaliera OO.RR...
NCT07761208
Turkish Version of the Pictorial Pain Interference QuestionnaireIstinye UniversityNot Yet Recruiting
NCT07761208Not Yet Recruiting
—
Turkish Version of the Pictorial Pain Interference QuestionnaireIstinye University
NCT07759661
Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination TherapiesIRCCS San RaffaeleNot Yet Recruiting
NCT07759661Not Yet Recruiting
—
Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Perso...IRCCS San Raffaele
NCT07761923
Preserving Muscle Mass During Incretin-Induced Weight LossKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07761923Not Yet Recruiting
Not Applicable
Preserving Muscle Mass During Incretin-Induced Weight LossKarolinska Institutet
Result Breakdown
Not yet recruiting19 (95%)
Completed1 (5%)
not_applicable8 (40%)
Phase 14 (20%)
Not Specified3 (15%)
Phase 32 (10%)
Phase 22 (10%)
Phase 41 (5%)